FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 334:472-473 February 15, 1996 Number 7 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Rozman, C.

To the Editor: As Rozman and Montserrat state in their fine overview of the treatment of chronic lymphocytic leukemia (Oct. 19 issue),¹ there are no curative options, so palliative treatment is a reasonable and important therapeutic goal. Unfortunately, however, the authors do not mention the important role of radiotherapy in the treatment of this disease. Radiotherapy has been used in many innovative ways in patients with chronic lymphocytic leukemia,² and irradiation of bulky localized lymphoid tissue is commonly performed as standard management.³ Such treatment results in excellent and durable control of symptoms. Radiation treatment is particularly important for masses impinging . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.